Faruqi and Faruqui, LLP Logo
Share this page

Pacira Pharmaceuticals, Inc. (PCRX)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Pacira Pharmaceuticals, Inc. (PCRX) To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Pacira Pharmaceuticals, Inc.  (“Pacira” or the “Company”) (NASDAQ: PCRX) of the December 2, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Pacira and certain executives.

A complaint has been filed in the District of New Jersey on behalf of all persons who purchased Pacira securities from April 9, 2012 through September 24, 2014, inclusive (the “Class Period”).

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

Specifically, the action alleges that during the Class Period, Pacira falsely stated that one its drugs, EXPAREL, was effective for pain relief for up to 72 hours and safe for use in cholecystectomy and colectomy procedures, and failed to disclose that a substantial portion of the Company’s revenues were derived from off-label marketing.

On September 25, 2014, Pacira announced that it had received a Warning Letter from the U.S. Food and Drug Administration’s Office of Prescription Drug Promotion regarding EXPAREL’s efficacy.

Following this news, the price of Pacira stock declined by $11.66, or over 10%, to close at $94.62 on September 25, 2014.

Take Action

If you invested in Pacira stock, bonds or options between April 9, 2012 through September 24, 2014, and would like to discuss your legal rights, you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Pacira’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 10/07/2014

Class Period:

  • 04/09/2012 - 09/24/2014

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.